ADVERTISEMENT
ADVERTISEMENT
Photograph of Humsa Venkatesh
Humsa Venkatesh Probes Cancer’s Grip on the Brain
At Brigham and Women’s Hospital, the cancer biologist is combining research into the tumor microenvironment with the principles of neuroscience to tease apart how cancers grow—and how to stop them.
Humsa Venkatesh Probes Cancer’s Grip on the Brain
Humsa Venkatesh Probes Cancer’s Grip on the Brain

At Brigham and Women’s Hospital, the cancer biologist is combining research into the tumor microenvironment with the principles of neuroscience to tease apart how cancers grow—and how to stop them.

At Brigham and Women’s Hospital, the cancer biologist is combining research into the tumor microenvironment with the principles of neuroscience to tease apart how cancers grow—and how to stop them.

  1. Home
  2. Subjects
  3. translational research
translational research
Don Ingber engineered cystic fibrosis airway chips that recapitulate patient symptoms.
A New Model of Lung Disease Paves the Way for Personalized Treatments
Nele Haelterman, PhD | May 9, 2022 | 4 min read
Scientists engineered a lung-on-a-chip model from patient cells that mimics cystic fibrosis.
Human large intestine tissue under microscope view
Mini-Guts to the Rescue: Introducing 3-D Organoid Cell Cultures
The Scientist Creative Services Team and MilliporeSigma | Jan 19, 2022 | 2 min read
A cost-effective 3-D organoid biobank provides a versatile translational research tool.
Erika More developed a jello-like tissue system to study how immune cells stimulate tissues and blood vessel growth.
An Engineer’s Perspective on Autoimmunity
Aparna Nathan | Dec 10, 2021 | 4 min read
Erika Moore builds biomaterials to study disparate lupus outcomes.
Lab dishes containing blue liquid
Study Finds Reproducibility Issues in High-Impact Cancer Papers
Catherine Offord | Dec 7, 2021 | 7 min read
Researchers involved in an eight-year project to reproduce the findings of more than 50 high-impact papers struggled to get enough information to even carry out most of the experiments.
CAR T Cells Derived from Stem Cells Target HIV Tissue Reservoirs in Monkeys
Berly McCoy, PhD | May 25, 2021 | 3 min read
Transplanted CAR stem cells persisted long term and showed multilineage engraftment in tissues that harbor HIV.
Engineered Immune Cells Eliminate Brain Cancer in Mice
Brooke Dulka, PhD | May 25, 2021 | 2 min read
Researchers developed a new CAR T-cell therapy that targets specific growth factor receptors in glioblastoma to eliminate brain tumors.
Environmental Cues Keep CAR T Cells on Track
Aparna Nathan | May 25, 2021 | 4 min read
Pairing CARs with a synthetic receptor makes T cells more lethal tumor killers.
Mary Jeanne Kreek, heroin, addiction, methadone, drug addiction, The Rockefeller University,
Mary Jeanne Kreek, Methadone Developer, Dies at 84
Asher Jones | Mar 31, 2021 | 2 min read
A physician and neurobiologist at the Rockefeller University who specialized in addiction research, Kreek was best known for her work on developing the treatment for heroin addiction.
The MSC: Regeneration Orchestrator
The Scientist Staff | Nov 16, 2020 | 7 min read
Scientists uncover the promise of mesenchymal stem cells (MSCs), also known as medicinal signaling cells, to modulate the immune system and regenerate tissue.
Thwarting a Pandemic: COVID-19 Vaccine Strategies
The Scientist Creative Services Team | Aug 6, 2020 | 1 min read
Download this poster to learn about promising vaccine candidates for COVID-19!
Biobanking and the Future of Precision Medicine
The Scientist Creative Services Team | Aug 4, 2020 | 1 min read
Erik Steinfelder and Bogi Eliasen will examine the importance of biobanking in precision medicine, from early-stage research to diagnostics and treatments.
An Alternative Route to Anesthesia-Induced Anaphylaxis
Ruth Williams | Jul 10, 2019 | 3 min read
A study in patients identifies a nontraditional immune pathway that can cause a severe reaction to anesthetic drugs.
Chemogenetics Method Uses Anti-Smoking Drug to Control Cells
Ruth Williams | Mar 14, 2019 | 3 min read
A new set of engineered receptors responds to an FDA-approved drug to provide the most potent chemogenetic toolkit to date.
Will the Noninvasive Glucose Monitoring Revolution Ever Arrive?
Catherine Offord | Oct 12, 2017 | 8 min read
A needle-free alternative to the finger-prick test would be a godsend for many sufferers of diabetes, but the industry has yet to clear the technological hurdles.
California Institutes to Merge
Jef Akst | Oct 25, 2016 | 1 min read
The Scripps Research Institute will join forces with the California Institute for Biomedical Research.
ADVERTISEMENT
ADVERTISEMENT